| - GRCh37:
- Chr11:108201014
- GRCh38:
- Chr11:108330287
| ATM, C11orf65 | R2461S | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jun 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:193091400
- GRCh38:
- Chr1:193122270
| CDC73 | E24* | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Jun 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577154
- GRCh38:
- Chr11:64809682
| MEN1 | L143R | Multiple endocrine neoplasia, type 1 | Likely pathogenic (May 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577445
- GRCh38:
- Chr11:64809973
| MEN1 | H46L | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Apr 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572626
- GRCh38:
- Chr11:64805154
| MEN1 | F375fs, F410fs, F415fs, F417fs, F452fs, F457fs | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Apr 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572512
- GRCh38:
- Chr11:64805040
| MEN1 | E413D, E448D, E453D, E455D, E490D, E495D | Multiple endocrine neoplasia, type 1 | Uncertain significance (Feb 11, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575120-64576450
| MEN1 | | Multiple endocrine neoplasia, type 1 | Pathogenic (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577559-64578852
| MEN1 | | Multiple endocrine neoplasia, type 1 | Pathogenic (Sep 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573097-64575581
| MEN1 | | Multiple endocrine neoplasia, type 1 | Pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573811
- GRCh38:
- Chr11:64806339
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (May 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573730
- GRCh38:
- Chr11:64806258
| MEN1 | W306C, W341C, W346C | Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577155
- GRCh38:
- Chr11:64809683
| MEN1 | L143V | Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574524
- GRCh38:
- Chr11:64807052
| MEN1 | P256S, P291S, P296S | Multiple endocrine neoplasia, type 1 | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572261
- GRCh38:
- Chr11:64804789
| MEN1 | R405G, R425G, R460G, R465G, R467G, R502G, R507G | Multiple endocrine neoplasia, type 1 | Uncertain significance (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575519
- GRCh38:
- Chr11:64808047
| MEN1 | Q166H, Q171H | Multiple endocrine neoplasia, type 1 | Uncertain significance (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577344
- GRCh38:
- Chr11:64809872
| MEN1 | V80M | Multiple endocrine neoplasia, type 1 | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574463
- GRCh38:
- Chr11:64806991
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577437
- GRCh38:
- Chr11:64809965
| MEN1 | A49S | Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577565
- GRCh38:
- Chr11:64810093
| MEN1 | A6V | Multiple endocrine neoplasia, type 1 | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577250
- GRCh38:
- Chr11:64809778
| MEN1 | G111D | Multiple endocrine neoplasia, type 1 | Uncertain significance (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577250
- GRCh38:
- Chr11:64809778
| MEN1 | G111fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575154
- GRCh38:
- Chr11:64807682
| MEN1 | | Multiple endocrine neoplasia, type 1 | Pathogenic (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577162
- GRCh38:
- Chr11:64809690
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572243
- GRCh38:
- Chr11:64804771
| MEN1 | E411Q, E473Q, E471Q, E508Q, E431Q, E513Q, E466Q | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jan 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572686
- GRCh38:
- Chr11:64805214
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573692
- GRCh38:
- Chr11:64806220
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574633
- GRCh38:
- Chr11:64807161
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572601
- GRCh38:
- Chr11:64805129
| MEN1 | G424S, G426S, G461S, G466S, G384S, G419S | not provided, Multiple endocrine neoplasia, type 1, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jan 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:64577165
- GRCh38:
- Chr11:64809693
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572198
- GRCh38:
- Chr11:64804726
| MEN1 | R481W, R523W, R446W, R486W, R488W, R426W, R528W | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 13, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:64573687
- GRCh38:
- Chr11:64806215
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577580
- GRCh38:
- Chr11:64810108
| MEN1 | M1K | Multiple endocrine neoplasia, type 1 | Pathogenic (Jan 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577449
- GRCh38:
- Chr11:64809977
| MEN1 | E45Q | Multiple endocrine neoplasia, type 1 | Pathogenic (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577296
- GRCh38:
- Chr11:64809824
| MEN1 | Q96* | Multiple endocrine neoplasia, type 1 | Pathogenic (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577261-64577262
- GRCh38:
- Chr11:64809789-64809790
| MEN1 | R108fs | Multiple endocrine neoplasia, type 1 | Pathogenic/Likely pathogenic (Mar 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:64577166
- GRCh38:
- Chr11:64809694
| MEN1 | H139P | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575553
- GRCh38:
- Chr11:64808081
| MEN1 | S160F, S155F | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575468
- GRCh38:
- Chr11:64807996
| MEN1 | W188*, W183* | Multiple endocrine neoplasia, type 1 | Pathogenic (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575443
- GRCh38:
- Chr11:64807971
| MEN1 | Q192*, Q197* | Multiple endocrine neoplasia, type 1 | Pathogenic (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574516
- GRCh38:
- Chr11:64807044
| MEN1 | G259fs, G299fs, G294fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572625
- GRCh38:
- Chr11:64805153
| MEN1 | A376P, A411P, A416P, A418P, A453P, A458P | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572243-64572246
- GRCh38:
- Chr11:64804771-64804774
| MEN1 | A470fs, A507fs, A465fs, A430fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571907
- GRCh38:
- Chr11:64804435
| MEN1 | Q523*, Q578*, Q585*, Q620*, Q543*, Q583*, Q625* | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573691
- GRCh38:
- Chr11:64806219
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571827
- GRCh38:
- Chr11:64804355
| MEN1 | K604N, K646N, K651N, K549N, K569N, K609N, K611N | Multiple endocrine neoplasia, type 1 | Uncertain significance (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575520
- GRCh38:
- Chr11:64808048
| MEN1 | Q166P, Q171P | Multiple endocrine neoplasia, type 1 | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574526
- GRCh38:
- Chr11:64807054
| MEN1 | E295G, E290G, E255G | Multiple endocrine neoplasia, type 1 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577438-64577439
- GRCh38:
- Chr11:64809966-64809967
| MEN1 | A49fs | Multiple endocrine neoplasia, type 1 | Pathogenic (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574556
- GRCh38:
- Chr11:64807084
| MEN1 | L245*, L280*, L285* | Multiple endocrine neoplasia, type 1 | Pathogenic (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577479
- GRCh38:
- Chr11:64810007
| MEN1 | V35L | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577553
- GRCh38:
- Chr11:64810081
| MEN1 | L10P | Multiple endocrine neoplasia, type 1 | Uncertain significance (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575518
- GRCh38:
- Chr11:64808046
| MEN1 | A167T, A172T | Multiple endocrine neoplasia, type 1 | Uncertain significance (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575349
- GRCh38:
- Chr11:64807877
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574570
- GRCh38:
- Chr11:64807098
| MEN1 | | Multiple endocrine neoplasia, type 1 | Uncertain significance (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572248
- GRCh38:
- Chr11:64804776
| MEN1 | A409E, A469E, A511E, A429E, A471E, A464E, A506E | Multiple endocrine neoplasia, type 1, Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:64573852
- GRCh38:
- Chr11:64806380
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Apr 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573094
- GRCh38:
- Chr11:64805622
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574580
- GRCh38:
- Chr11:64807108
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575588
- GRCh38:
- Chr11:64808116
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571981
- GRCh38:
- Chr11:64804509
| MEN1 | F498Y, F518Y, F553Y, F558Y, F560Y, F595Y, F600Y | Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574709
- GRCh38:
- Chr11:64807237
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572106
- GRCh38:
- Chr11:64804634
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574533
- GRCh38:
- Chr11:64807061
| MEN1 | E293*, E253*, E288* | Multiple endocrine neoplasia, type 1 | Pathogenic (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574558
- GRCh38:
- Chr11:64807086
| MEN1 | | Multiple endocrine neoplasia, type 1 | Pathogenic (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571859
- GRCh38:
- Chr11:64804387
| MEN1 | T594P, T599P, T539P, T601P, T636P, T641P, T559P | Multiple endocrine neoplasia, type 1 | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574501
- GRCh38:
- Chr11:64807029
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572623
- GRCh38:
- Chr11:64805151
| MEN1 | | Multiple endocrine neoplasia, type 1, Hereditary cancer-predisposing syndrome | Likely benign (May 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:64572622
- GRCh38:
- Chr11:64805150
| MEN1 | H417fs, H454fs, H412fs, H377fs | Multiple endocrine neoplasia, type 1 | Pathogenic (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577341
- GRCh38:
- Chr11:64809869
| MEN1 | A81fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577483
- GRCh38:
- Chr11:64810011
| MEN1 | D33E | Multiple endocrine neoplasia, type 1 | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572286
- GRCh38:
- Chr11:64804814
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577540-64577541
- GRCh38:
- Chr11:64810068-64810069
| MEN1 | R14fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571883
- GRCh38:
- Chr11:64804411
| MEN1 | Q531*, Q586*, Q591*, Q628*, Q551*, Q593*, Q633* | Multiple endocrine neoplasia, type 1 | Likely pathogenic (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577174-64577175
- GRCh38:
- Chr11:64809702-64809703
| MEN1 | D136fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571934
- GRCh38:
- Chr11:64804462
| MEN1 | K534E, K616E, K514E, K611E, K576E, K569E, K574E | Multiple endocrine neoplasia, type 1 | Uncertain significance (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577419
- GRCh38:
- Chr11:64809947
| MEN1 | P55S | Multiple endocrine neoplasia, type 1 | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572550-64572551
- GRCh38:
- Chr11:64805078-64805079
| MEN1 | W401fs, W478fs, W436fs, W441fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577347
- GRCh38:
- Chr11:64809875
| MEN1 | P79A | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jan 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577499-64577500
- GRCh38:
- Chr11:64810027-64810028
| MEN1 | G28N | Multiple endocrine neoplasia, type 1 | Uncertain significance (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577409-64577420
- GRCh38:
- Chr11:64809937-64809948
| MEN1 | | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575345
- GRCh38:
- Chr11:64807873
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64571966-64571997
- GRCh38:
- Chr11:64804494-64804525
| MEN1 | | Multiple endocrine neoplasia, type 1 | Pathogenic (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575416
- GRCh38:
- Chr11:64807944
| MEN1 | K201E, K206E | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575380
- GRCh38:
- Chr11:64807908
| MEN1 | A218T, A213T | Multiple endocrine neoplasia, type 1 | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577365
- GRCh38:
- Chr11:64809893
| MEN1 | G73C | Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573837
- GRCh38:
- Chr11:64806365
| MEN1 | I306V, I311V, I271V | Multiple endocrine neoplasia, type 1 | Uncertain significance (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572139
- GRCh38:
- Chr11:64804667
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64573718
- GRCh38:
- Chr11:64806246
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575411
- GRCh38:
- Chr11:64807939
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574510
- GRCh38:
- Chr11:64807038
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577474
- GRCh38:
- Chr11:64810002
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572684
- GRCh38:
- Chr11:64805212
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Dec 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64572175
- GRCh38:
- Chr11:64804703
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577387
- GRCh38:
- Chr11:64809915
| MEN1 | S66fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577501
- GRCh38:
- Chr11:64810029
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577322-64577323
- GRCh38:
- Chr11:64809850-64809851
| MEN1 | A87fs | Multiple endocrine neoplasia, type 1 | Pathogenic (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64577363
- GRCh38:
- Chr11:64809891
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64574480
- GRCh38:
- Chr11:64807008
| MEN1 | | Multiple endocrine neoplasia, type 1 | Uncertain significance (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575570
- GRCh38:
- Chr11:64808098
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:64575534
- GRCh38:
- Chr11:64808062
| MEN1 | | Multiple endocrine neoplasia, type 1 | Likely benign (Sep 17, 2022) | criteria provided, single submitter |